Connection

Gary Gilkeson to Interferon Type I

Back to Details
This is a "connection" page, showing publications Gary Gilkeson has written about Interferon Type I.
Gary Gilkeson
Connection Strength
0.463
Interferon Type I
  1. COVID-19 mRNA vaccine BNT162b2 induces autoantibodies against type I interferons in a healthy woman. J Autoimmun. 2022 10; 132:102896.
    View in: PubMed
    Score: 0.208
  2. Estrogen Receptor a Deficiency Modulates TLR Ligand-Mediated PDC-TREM Expression in Plasmacytoid Dendritic Cells in Lupus-Prone Mice. J Immunol. 2015 Dec 15; 195(12):5561-71.
    View in: PubMed
    Score: 0.130
  3. The role of genetic variation near interferon-kappa in systemic lupus erythematosus. J Biomed Biotechnol. 2010; 2010.
    View in: PubMed
    Score: 0.090
  4. Plasmacytoid dendritic cell distribution and maturation are altered in lupus prone mice prior to the onset of clinical disease. Clin Immunol. 2017 02; 175:109-114.
    View in: PubMed
    Score: 0.035
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.